Evaluation of KRAS, NRAS and BRAF Mutations Detection in Plasma Using an Automated System for Patients With Metastatic Colorectal Cancer

PLoS ONE - United States
doi 10.1371/journal.pone.0227294
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Prevalence of KRAS, BRAF, PI3K and EGFR Mutations Among Asian Patients With Metastatic Colorectal Cancer

Oncology Letters
Cancer ResearchOncology
2015English

Accurate Detection of KRAS, NRAS and BRAF Mutations in Metastatic Colorectal Cancers by Bridged Nucleic Acid-Clamp Real-Time PCR

BMC Medical Genomics
Genetics
2019English

Molecular Pathological Epidemiology of Colorectal Cancer in Chinese Patients With KRAS and BRAF Mutations

Oncotarget
Oncology
2015English

Association of BRAF Mutations With Survival and Recurrence in Surgically Treated Patients With Metastatic Colorectal Liver Cancer

JAMA Surgery
Surgery
2018English

Mutations in KRAS Codon 12 Predict Poor Survival in Chinese Patients With Metastatic Colorectal Cancer

Oncology Letters
Cancer ResearchOncology
2017English

Cetuximab Alone or With Irinotecan for Resistant KRAS-, NRAS-, BRAF- And PIK3CA- Wild-Type Metastatic Colorectal Cancer: The AGITG Randomised Phase II ICECREAM Study

Clinical Colorectal Cancer
OncologyGastroenterology
2018English

Mutation Pattern of KRAS and BRAF Oncogenes in Colorectal Cancer Patients

Neoplasma
Cancer Research
2012English

P1.13-45 Coexistence of Activating BRAF and KRAS Mutations in Lung Cancer Patients

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

FOLFIRI Plus Panitumumab in the Treatment of Wild-Type KRAS and Wild-Type NRAS Metastatic Colorectal Cancer

World Journal of Surgical Oncology
SurgeryOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy